ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: T-DM1
Sponsor: Dana-Farber Cancer Institute
Collaborators: Susan G. Komen Breast Cancer Foundation|Gateway for Cancer Research